Tom Blumenthal at the Crnic Lab
Tom Blumenthal in the lab at the Linda Crnic Institute for Down Syndrome

Global Briefs Congress on
Critical Down Syndrome Research
Wednesday, September 10, 2014
8:00 am to 9:30 am
Cannon House Office Building Room 122

The Congressional Down Syndrome Briefing Series is co-organized by the Global Down Syndrome Foundation, the National Down Syndrome Congress and the National Down Syndrome Society. This important briefing will focus on global research findings related to Down syndrome, including the link to Alzheimer’s disease, and opportunities for future research efforts.

Among the speakers updating members of Congress about the latest research will be:

  • Members of the Congressional Down Syndrome Caucus
  • Michelle Livingston, Senior Director of Operations and Government Affairs for the Global Down Syndrome Foundation
  • Dr. Thomas Blumenthal, Executive Director, Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine
  • Dr. Huntington Potter, Director of Alzheimer’s Research at the Crnic Institute and the University of Colorado School of Medicine’s Department of Neurology
  • Jon Colman, President of the National Down Syndrome Society
  • Sara Weir, Vice President of Advocacy and Affiliate Relations for the National Down Syndrome Society
  • Susan Goodman, Director of Government Affairs for the National Down Syndrome Congress
Rep. Eleanor Holmes Norton
Alzheimer's Briefing
Rep. Mike Coffman

Our Congressional briefing is held in conjunction with the Congressional Down Syndrome Caucus, and Representatives Cathy McMorris Rodgers, Pete Sessions, Chris Van Hollen and Eleanor Holmes Norton

RSVP to Deana Perlmutter at dperlmutter@globaldownsyndrome.org

Dr. Huntington Potter and Friends
Dr Huntington Potter and Friends

Dr. Huntington Potter and Alzheimer’s-Down syndrome research

Dr. Potter is the scientist who discovered the mechanistic relationship between Down syndrome and Alzheimer’s disease. Learn more about his groundbreaking research and why studying people with Down syndrome could benefit both people with Down syndrome and people with Alzheimer’s disease.

Global’s Alzheimer’s initiatives

Global is committed to raising awareness and important research funding for Down syndrome and Alzheimer’s disease. Learn more about Global’s Alzheimer’s initiatives.

Recent Posts